Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details)

v3.22.2
Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities     4,137,195  
Common stock warrants        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities 18,410,000,000 0 18,410,000,000 0
Earnout Shares        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities 3,510,405,000 0 3,510,405,000 0
Unvested RSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities 4,137,195 0   0